March 19-22, 2018 New York, USA
June 20 - 22, 2018 Shanghai, China Booth number: W2C22b
October 9 – 11, 2018 Feria de Madrid, Spain
Huapont Pharm has been focusing on retinoids since start-up of its business, and are proud of a lot of experts with rich developing and manufacturing experiences,
We manufacturing APIs including:
● First generation:
Tretinoin (Retinoic acid), Isotretinoin and alitretinoin
● Second generation:
● Third generation:
Adapalene, Bexarotene and Tazarotene
As well as manufacturing Tretinoin cream, Isotretinoin soft caps, Acitretin caps, Adapalene cream and Tazarotene cream/gel.
A new finished product plant of Huapont Pharm is to use in 2018 which covers 13516 m2 with over 130000 m2 total construction area. It is designed to comply with EU&US GMP with over￥1 billion total investment.
The new plant has 7 production lines, and the annual production capacity set to be 5 times of the old plant: 25 million units for external preparations, 35 million units for external preparations (Hormone), 2 billion units for tablets, 0.6 billion units for hard capsules, 7.2 million units for sterilization preparations, 50 million units for oral solution and 25 units for soft capsules.
Copyright © 2018 Chongqing Huapont Pharmaceutical Co., Ltd. All Rights Reserved.